New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Celularity Inc.
CELU
Shape
US Flag

NASDAQ

EPS improving

EPS improving

41M

Biotechnology

Next Earning date - 31 Dec 2024

41M

Biotechnology

Next Earning date - 31 Dec 2024

1.86USD
Shape-0.31 ( -14.29%)
favorite-chart

Relative Strenght

10
favorite-chart

Volume Buzz

558%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

77%

Quote Panel

Shape
Updated October 26, 2024
1W -11.85 % 1M -37.79 % 3M -38.41 % 1Y -11.00 %

Key Metrics

Shape
  • Market Cap

    40.89M


  • Shares Outstanding

    21.98M


  • Share in Float

    10.71M


  • Dividende

    0


  • Earning Date

    31 Dec 2024


  • Price Target

    1.86


  • Average Volume

    16973


  • Beta

    0.443


  • Range

    1.59-7.97


  • Industry

    Biotechnology


  • Website

    https://www.celularity.com


  • Sector

    Healthcare


Fundamentals

Shape

0.66x

P/E Ratio

1.22x

P/S Ratio

1.28x

P/B Ratio

2.1

Debt/Equity

-460.3%

Net Margin

$-110.8

EPS

How CELU compares to sector?

P/E Ratio

Relative Strength

Shape

CELU

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$66M

Shape346%

2025-Revenue

$0.42

Shape59%

2025-EPS

$53M

Shape-186%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Truist Financial

downgrade

Previous: Not converted

2022-04-26

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+112%

0.32
vs -2.69

Q3.22

arrow
arrow

-92%

0.3
vs 4

Q4.22

arrow
arrow

N/A

NA
vs NA

Q1.23

arrow
arrow

N/A

-0.03
vs -0.30

Q2.23

arrow
arrow

+963%

3.4
vs 0.32

Q3.23

arrow
arrow

N/A

NA
vs 0.3

Q4.23

arrow
arrow

N/A

-0.60
vs NA

Q1.24

arrow
arrow

N/A

NA
vs -0.03

Q3.24

arrow
arrow

N/A

-1.40
vs NA

Q4.24

arrow
arrow

N/A

-1.40
vs -0.60

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+18%

3.8M  vs 3.2M

Q3.22

arrow
arrow

-61%

4.1M  vs 10.6M

Q4.22

arrow
arrow

-15%

4.1M  vs 4.9M

Q1.23

arrow
arrow

-34%

3.9M  vs 5.9M

Q2.23

arrow
arrow

-22%

2.9M  vs 3.8M

Q3.23

arrow
arrow

-8%

3.8M  vs 4.1M

Q4.23

arrow
arrow

+193%

12.1M  vs 4.1M

Q1.24

arrow
arrow

+273%

14.7M  vs 3.9M

Q3.24

arrow
arrow

+27%

4.8M  vs 3.8M

Q4.24

arrow
arrow

-56%

5.3M  vs 12.1M

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

+32%

0.32
vs -0.70

Q3.22

arrow
arrow

+3%

0.03
vs 0.32

Q4.22

arrow
arrow

+12%

0.12
vs 0.03

Q1.23

arrow
arrow

-41%

-0.41
vs 0.12

Q2.23

arrow
arrow

-40%

-0.40
vs -0.41

Q3.23

arrow
arrow

-310%

-3.10
vs -0.40

Q4.23

arrow
arrow

+23%

0.23
vs -3.10

Q1.24

arrow
arrow

-70%

-0.70
vs 0.23

Institutionnal OwnershipShape

status-upQoQ

Q2.22

arrow
arrow

76

76
vs 47

62%

Q3.22

arrow
arrow

77

77
vs 76

1%

Q4.22

arrow
arrow

80

80
vs 77

4%

Q1.23

arrow
arrow

62

62
vs 80

-22%

Q2.23

arrow
arrow

57

57
vs 62

-8%

Q3.23

arrow
arrow

47

47
vs 57

-18%

Q4.23

arrow
arrow

38

38
vs 47

-19%

Q1.24

arrow
arrow

1

1
vs 38

-97%

Earnings Growth

Latest News